ACE and Hypokalemia: Routine usage of potassium-sparing agent (spironolactone, eplerenone, or amiloride), angiotensin-converting enzyme inhibitor, or angiotensin receptor blocker to ameliorate hypokalemia is not recommended because these medications can exacerbate renal salt wasting and polyuria (20, 35).